Check-Cap Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEK research report →
Companywww.check-cap.com
Check-Cap Ltd. , a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
- CEO
- David Lontini
- IPO
- 2015
- Employees
- 85
- HQ
- Isfiya, IL
Price Chart
Valuation
- Market Cap
- $9.83M
- P/E
- 2.75
- P/S
- 0.00
- P/B
- 3.32
- EV/EBITDA
- 2.46
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 416.71%
- ROIC
- -68.72%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-25,149,000 · -43.15%
- EPS
- $-4.30 · -43.33%
- Op Income
- $-25,949,000
- FCF YoY
- 99.95%
Performance & Tape
- 52W High
- $3.13
- 52W Low
- $0.56
- 50D MA
- $1.72
- 200D MA
- $1.08
- Beta
- 0.46
- Avg Volume
- 2.99M
Get TickerSpark's AI analysis on CHEK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CHEK Coverage
We haven't published any research on CHEK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHEK Report →